Which factors increase the risk of myelodysplastic syndromes (MDS) in patients with aplastic anemia?

Updated: Jan 29, 2021
  • Author: Sameer Bakhshi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Kulasekararaj and colleagues reported that the presence of somatic mutations (including ASXL1DNMT3A, and BCOR) in patients with aplastic anemia for more than 6 months was associated with 40% risk of transformation to MDS. Nearly a fifth of patients with aplastic anemia have mutations in genes typically seen in myeloid malignancies that predicted for later transformation to MDS. [55]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!